The Express Scripts Holding Co.-Bond has a maturity date of 3/1/2027 and offers a coupon of 3.4000%. The payment of the coupon will take place 2,0 times per biannual on the 01.09.. At the current ...

On Tuesday, October 27, Express Scripts will announce its third-quarter results after the market closes. While shares have pulled back about 7% since it last reported results, the healthcare ...

Express Scripts Holding, a pharmacy benefit manager and specialty pharmacy that negotiates drug prices for 85 million people, plans to expand its full network offerings to “pharmacies predominantly ...

Express Scripts Holding Co. defeated a bid by retail drugstores to suspend its $29.1 billion purchase of Medco Health Solutions Inc. while a lawsuit challenging the takeover is pending. Express ...

Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Editor's note: An earlier version of this story incorrectly stated that a specific type of insulin was excluded from CVS 2017 ...

On July 20, 2011, Express Scripts, Inc. ("ESI") entered into a definitive merger agreement (the "Merger Agreement") with Medco Health Solutions, Inc. ("Medco"), which was amended by Amendment No. 1 ...

Express Scripts Holding Company (NASDAQ: ESRX) reported first-quarter results on April 25. Despite being locked in a heated contract dispute with its biggest customer, the pharmacy benefits manager ...

Express Scripts Holding Co. shares tumbled Wednesday, a day after the pharmacy benefits manager lowered its 2014 forecast, disappointed Wall Street with its first-quarter report and said it received a ...

Healthcare management and administration service company Express Scripts is scheduled to report second-quarter results on Tuesday, July 28 after market close. With shares hitting all-time highs before ...

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more. By Reed Abelson and ...

Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found. By Chris Hamby New legislation would force ...